Matches in SemOpenAlex for { <https://semopenalex.org/work/W2886311884> ?p ?o ?g. }
- W2886311884 abstract "While it is has been proven that tranexamic acid (TXA) reduces blood loss in primary total hip and knee arthroplasty (THA and TKA), there is little published evidence on the use of TXA beyond 3 h post-operatively. Most blood loss occurs after wound closure and the primary aim of this study is to determine if the use of oral TXA post-operatively for up to 24 h will reduce calculated blood loss at 48 h beyond an intra-operative intravenous bolus alone following primary THA and TKA. To date, most TXA studies have excluded patients with a history of thromboembolic disease.This is a phase IV, single-centred, open-label, parallel-group, randomised controlled trial. Participants are randomised to one of three groups: group 1, an intravenous (IV) bolus of TXA peri-operatively plus oral TXA post-operatively for 24 h; group 2, an IV bolus of TXA peri-operatively or group 3, standard care (no TXA). Eligible participants, including those with a history of thromboembolic disease, are allocated to these groups with a 2:2:1 allocation ratio. The primary outcome is the indirectly calculated blood loss 48 h after surgery. Researchers and patients are not blinded to the treatment; however, staff processing blood samples are. Originally 1166 participants were required to complete this study, 583 THA and 583 TKA. However, following an interim analysis after 100 THA and 100 TKA participants had been recruited to the study, the data monitoring ethics committee recommended stopping group 3 (standard care).TRAC-24 will help to determine whether an extended TXA dosing regimen can further reduce blood loss following primary THA and TKA. By including patients with a history of thromboembolic disease, this study will add to our understanding of the safety profile of TXA in this clinical situation.ISRCTN registry, ISRCTN58790500 . Registered on 3 June 2016, EudraCT: 2015-002661-36." @default.
- W2886311884 created "2018-08-22" @default.
- W2886311884 creator A5006683531 @default.
- W2886311884 creator A5007858416 @default.
- W2886311884 creator A5024502519 @default.
- W2886311884 creator A5026723766 @default.
- W2886311884 creator A5036302208 @default.
- W2886311884 creator A5038846216 @default.
- W2886311884 creator A5041283642 @default.
- W2886311884 creator A5044901187 @default.
- W2886311884 creator A5045273192 @default.
- W2886311884 creator A5046896627 @default.
- W2886311884 creator A5053979443 @default.
- W2886311884 creator A5059904362 @default.
- W2886311884 creator A5062366073 @default.
- W2886311884 creator A5066034546 @default.
- W2886311884 creator A5070447063 @default.
- W2886311884 creator A5071293067 @default.
- W2886311884 creator A5081530481 @default.
- W2886311884 creator A5090239373 @default.
- W2886311884 creator A5091401834 @default.
- W2886311884 creator A5091764936 @default.
- W2886311884 date "2018-07-31" @default.
- W2886311884 modified "2023-09-27" @default.
- W2886311884 title "Assessment of the effect of addition of 24 hours of oral tranexamic acid post-operatively to a single intraoperative intravenous dose of tranexamic acid on calculated blood loss following primary hip and knee arthroplasty (TRAC-24): a study protocol for a randomised controlled trial" @default.
- W2886311884 cites W127019677 @default.
- W2886311884 cites W1903132268 @default.
- W2886311884 cites W1983583305 @default.
- W2886311884 cites W1986837360 @default.
- W2886311884 cites W2039547663 @default.
- W2886311884 cites W2040538032 @default.
- W2886311884 cites W2042878569 @default.
- W2886311884 cites W2054793869 @default.
- W2886311884 cites W2098686310 @default.
- W2886311884 cites W2102246395 @default.
- W2886311884 cites W2107339086 @default.
- W2886311884 cites W2111373463 @default.
- W2886311884 cites W2121153627 @default.
- W2886311884 cites W2123622204 @default.
- W2886311884 cites W2128863777 @default.
- W2886311884 cites W2148306825 @default.
- W2886311884 cites W2156515605 @default.
- W2886311884 cites W2167084145 @default.
- W2886311884 cites W2242521383 @default.
- W2886311884 cites W2267873203 @default.
- W2886311884 cites W2305316613 @default.
- W2886311884 cites W2307702963 @default.
- W2886311884 cites W2338438098 @default.
- W2886311884 cites W2345414727 @default.
- W2886311884 cites W2506516125 @default.
- W2886311884 cites W2531575551 @default.
- W2886311884 cites W2563035970 @default.
- W2886311884 cites W2588642758 @default.
- W2886311884 cites W2604564256 @default.
- W2886311884 cites W2625662748 @default.
- W2886311884 cites W2764139256 @default.
- W2886311884 cites W4297066808 @default.
- W2886311884 cites W50135966 @default.
- W2886311884 doi "https://doi.org/10.1186/s13063-018-2784-3" @default.
- W2886311884 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6069723" @default.
- W2886311884 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30064517" @default.
- W2886311884 hasPublicationYear "2018" @default.
- W2886311884 type Work @default.
- W2886311884 sameAs 2886311884 @default.
- W2886311884 citedByCount "6" @default.
- W2886311884 countsByYear W28863118842019 @default.
- W2886311884 countsByYear W28863118842020 @default.
- W2886311884 countsByYear W28863118842021 @default.
- W2886311884 countsByYear W28863118842022 @default.
- W2886311884 crossrefType "journal-article" @default.
- W2886311884 hasAuthorship W2886311884A5006683531 @default.
- W2886311884 hasAuthorship W2886311884A5007858416 @default.
- W2886311884 hasAuthorship W2886311884A5024502519 @default.
- W2886311884 hasAuthorship W2886311884A5026723766 @default.
- W2886311884 hasAuthorship W2886311884A5036302208 @default.
- W2886311884 hasAuthorship W2886311884A5038846216 @default.
- W2886311884 hasAuthorship W2886311884A5041283642 @default.
- W2886311884 hasAuthorship W2886311884A5044901187 @default.
- W2886311884 hasAuthorship W2886311884A5045273192 @default.
- W2886311884 hasAuthorship W2886311884A5046896627 @default.
- W2886311884 hasAuthorship W2886311884A5053979443 @default.
- W2886311884 hasAuthorship W2886311884A5059904362 @default.
- W2886311884 hasAuthorship W2886311884A5062366073 @default.
- W2886311884 hasAuthorship W2886311884A5066034546 @default.
- W2886311884 hasAuthorship W2886311884A5070447063 @default.
- W2886311884 hasAuthorship W2886311884A5071293067 @default.
- W2886311884 hasAuthorship W2886311884A5081530481 @default.
- W2886311884 hasAuthorship W2886311884A5090239373 @default.
- W2886311884 hasAuthorship W2886311884A5091401834 @default.
- W2886311884 hasAuthorship W2886311884A5091764936 @default.
- W2886311884 hasBestOaLocation W28863118841 @default.
- W2886311884 hasConcept C141071460 @default.
- W2886311884 hasConcept C168563851 @default.
- W2886311884 hasConcept C2779637338 @default.
- W2886311884 hasConcept C2991743468 @default.
- W2886311884 hasConcept C42219234 @default.
- W2886311884 hasConcept C43376680 @default.
- W2886311884 hasConcept C61943457 @default.
- W2886311884 hasConcept C71924100 @default.
- W2886311884 hasConceptScore W2886311884C141071460 @default.